vs
美国国际集团（AII）与STEM, INC.（STEM）财务数据对比。点击上方公司名可切换其他公司
美国国际集团的季度营收约是STEM, INC.的1.4倍（$68.1M vs $47.1M），美国国际集团净利率更高（30.7% vs -33.9%，领先64.5%）
美国国际集团（AIG）是一家美国跨国金融保险集团，业务遍及全球80多个国家和地区，截至2023年共有雇员25200人。集团核心业务分为三大板块：一般保险、人寿与退休服务，另设有一家独立的科技赋能子公司。
该公司是一家公开上市的生物制药企业，总部位于加利福尼亚州纽瓦克，专注研发纯化人类神经干细胞，旨在治疗中枢神经系统疾病与瘫痪，其所研发的神经干细胞可分化为中枢神经系统的神经元、星形胶质细胞与少突胶质细胞这三大主要细胞类型。
AII vs STEM — 直观对比
营收规模更大
AII
是对方的1.4倍
$47.1M
净利率更高
AII
高出64.5%
-33.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $68.1M | $47.1M |
| 净利润 | $20.9M | $-16.0M |
| 毛利率 | — | 48.9% |
| 营业利润率 | 43.0% | -17.7% |
| 净利率 | 30.7% | -33.9% |
| 营收同比 | — | -15.6% |
| 净利润同比 | — | 68.8% |
| 每股收益（稀释后） | $0.58 | $-4.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AIISTEM
| Q4 25 | $68.1M | $47.1M | ||
| Q3 25 | $62.0M | $38.2M | ||
| Q2 25 | $74.5M | $38.4M | ||
| Q1 25 | $71.9M | $32.5M | ||
| Q4 24 | — | $55.8M | ||
| Q3 24 | — | $29.3M | ||
| Q2 24 | — | $34.0M | ||
| Q1 24 | — | $25.5M |
净利润AIISTEM
| Q4 25 | $20.9M | $-16.0M | ||
| Q3 25 | $13.2M | $-23.8M | ||
| Q2 25 | $27.5M | $202.5M | ||
| Q1 25 | $38.1M | $-25.0M | ||
| Q4 24 | — | $-51.1M | ||
| Q3 24 | — | $-148.3M | ||
| Q2 24 | — | $-582.3M | ||
| Q1 24 | — | $-72.3M |
毛利率AIISTEM
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
营业利润率AIISTEM
| Q4 25 | 43.0% | -17.7% | ||
| Q3 25 | 30.3% | -33.6% | ||
| Q2 25 | 32.3% | -34.8% | ||
| Q1 25 | 59.7% | -65.0% | ||
| Q4 24 | — | -84.4% | ||
| Q3 24 | — | -493.2% | ||
| Q2 24 | — | -1705.5% | ||
| Q1 24 | — | -267.0% |
净利率AIISTEM
| Q4 25 | 30.7% | -33.9% | ||
| Q3 25 | 21.2% | -62.2% | ||
| Q2 25 | 36.9% | 527.8% | ||
| Q1 25 | 53.0% | -76.9% | ||
| Q4 24 | — | -91.6% | ||
| Q3 24 | — | -506.3% | ||
| Q2 24 | — | -1712.6% | ||
| Q1 24 | — | -283.9% |
每股收益（稀释后）AIISTEM
| Q4 25 | $0.58 | $-4.40 | ||
| Q3 25 | $0.67 | $-2.84 | ||
| Q2 25 | $1.62 | $-1.79 | ||
| Q1 25 | $2.78 | $-0.15 | ||
| Q4 24 | — | $-15.29 | ||
| Q3 24 | — | $-18.24 | ||
| Q2 24 | — | $-71.81 | ||
| Q1 24 | — | $-0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $222.0M | $48.9M |
| 总债务越低越好 | $618.0K | — |
| 股东权益账面价值 | $337.0M | $-249.4M |
| 总资产 | $1.2B | $308.9M |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资AIISTEM
| Q4 25 | $222.0M | $48.9M | ||
| Q3 25 | $171.9M | $43.1M | ||
| Q2 25 | $259.6M | $40.8M | ||
| Q1 25 | $236.4M | $58.6M | ||
| Q4 24 | — | $56.3M | ||
| Q3 24 | — | $75.4M | ||
| Q2 24 | — | $89.6M | ||
| Q1 24 | — | $112.8M |
总债务AIISTEM
| Q4 25 | $618.0K | — | ||
| Q3 25 | $721.0K | — | ||
| Q2 25 | $824.0K | — | ||
| Q1 25 | $926.0K | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AIISTEM
| Q4 25 | $337.0M | $-249.4M | ||
| Q3 25 | $315.9M | $-235.7M | ||
| Q2 25 | $301.9M | $-214.1M | ||
| Q1 25 | $186.1M | $-417.5M | ||
| Q4 24 | — | $-398.4M | ||
| Q3 24 | — | $-344.1M | ||
| Q2 24 | — | $-203.2M | ||
| Q1 24 | — | $371.6M |
总资产AIISTEM
| Q4 25 | $1.2B | $308.9M | ||
| Q3 25 | $1.4B | $362.6M | ||
| Q2 25 | $1.6B | $379.2M | ||
| Q1 25 | $1.1B | $405.1M | ||
| Q4 24 | — | $437.4M | ||
| Q3 24 | — | $537.8M | ||
| Q2 24 | — | $691.5M | ||
| Q1 24 | — | $1.3B |
负债/权益比AIISTEM
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $138.2M | $8.2M |
| 自由现金流经营现金流 - 资本支出 | $133.2M | — |
| 自由现金流率自由现金流/营收 | 195.6% | — |
| 资本支出强度资本支出/营收 | 7.4% | — |
| 现金转化率经营现金流/净利润 | 6.62× | — |
| 过去12个月自由现金流最近4个季度 | $216.1M | — |
8季度趋势，按日历期对齐
经营现金流AIISTEM
| Q4 25 | $138.2M | $8.2M | ||
| Q3 25 | $-7.5M | $11.4M | ||
| Q2 25 | $27.4M | $-21.3M | ||
| Q1 25 | $68.1M | $8.5M | ||
| Q4 24 | — | $-14.7M | ||
| Q3 24 | — | $-9.4M | ||
| Q2 24 | — | $-11.9M | ||
| Q1 24 | — | $-621.0K |
自由现金流AIISTEM
| Q4 25 | $133.2M | — | ||
| Q3 25 | $-11.9M | — | ||
| Q2 25 | $26.9M | — | ||
| Q1 25 | $68.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率AIISTEM
| Q4 25 | 195.6% | — | ||
| Q3 25 | -19.2% | — | ||
| Q2 25 | 36.1% | — | ||
| Q1 25 | 94.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度AIISTEM
| Q4 25 | 7.4% | — | ||
| Q3 25 | 7.2% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率AIISTEM
| Q4 25 | 6.62× | — | ||
| Q3 25 | -0.57× | — | ||
| Q2 25 | 1.00× | -0.11× | ||
| Q1 25 | 1.79× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
